CN Patent

CN105272982B — 利格列汀新晶型及其制备方法

Assigned to QILU PHARMACEUTICAL (HAINAN) CO Ltd · Expires 2017-06-16 · 9y expired

What this patent protects

本发明属于药物化学技术领域，具体涉及一种利格列汀的新晶型及其制备方法，该晶型具有良好的化学稳定性和晶型纯度，易于规模化制备，操作简单，能够更好地适用于制备药物制剂和规模化生产，具有广阔的应用前景。

USPTO Abstract

本发明属于药物化学技术领域，具体涉及一种利格列汀的新晶型及其制备方法，该晶型具有良好的化学稳定性和晶型纯度，易于规模化制备，操作简单，能够更好地适用于制备药物制剂和规模化生产，具有广阔的应用前景。

Drugs covered by this patent

Patent Metadata

Patent number
CN105272982B
Jurisdiction
CN
Classification
—
Expires
2017-06-16
Drug substance claim
No
Drug product claim
No
Assignee
QILU PHARMACEUTICAL (HAINAN) CO Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.